A retrospective study of intravenous pentamidine for PCP prophylaxis in adult patients with hematological malignancies-its utility during respiratory virus pandemics.
Background In Haematology, prophylaxis for Pneumocystis jirovecii pneumonia (PCP) is
recommended for patients undergoing hematopoietic stem cell transplantation and in …
recommended for patients undergoing hematopoietic stem cell transplantation and in …
[HTML][HTML] A retrospective study of intravenous pentamidine for Pneumocystis jirovecii pneumonia prophylaxis in adult patients with hematologic malignancies—its utility …
Objectives In hematology, prophylaxis for Pneumocystis jirovecii pneumonia (PCP) is
recommended for patients undergoing hematopoietic stem cell transplantation and in …
recommended for patients undergoing hematopoietic stem cell transplantation and in …
A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant
K Sweiss, J Anderson, S Wirth, A Oh… - Bone Marrow …, 2018 - nature.com
Prophylaxis for Pneumocystis jirovecii pneumonia (PJP) is recommended for patients
undergoing hematopoietic stem cell transplantation (HSCT) or intensive chemotherapy …
undergoing hematopoietic stem cell transplantation (HSCT) or intensive chemotherapy …
Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a …
WB Awad, A Asaad, N Al-Yasein, R Najjar - BMC Infectious Diseases, 2020 - Springer
Background Pneumocystis carinii pneumonia (PCP) prophylaxis is recommended after
hematopoietic stem cell transplantation (HSCT). In patients who are unable to take first-line …
hematopoietic stem cell transplantation (HSCT). In patients who are unable to take first-line …
Pneumocystis jirovecii pneumonia prophylaxis with intravenous pentamidine in adult allogeneic hematopoietic stem cell transplant patients
S McCollam, JS Lewis, J Bubalo… - Antimicrobial Agents and …, 2022 - Am Soc Microbiol
The purpose of this single-center retrospective case series was to evaluate the efficacy and
safety of 300-mg once-monthly intravenous (IV) pentamidine prophylaxis in 702 adult …
safety of 300-mg once-monthly intravenous (IV) pentamidine prophylaxis in 702 adult …
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation
R Diri, F Anwer, A Yeager… - Transplant Infectious …, 2016 - Wiley Online Library
Background Patients undergoing allogeneic hematopoietic stem cell transplantation (allo‐
HSCT) are at risk of numerous opportunistic infections. Pneumocystis jirovecii pneumonia …
HSCT) are at risk of numerous opportunistic infections. Pneumocystis jirovecii pneumonia …
Incidence of Pneumocystis Pneumonia in Immunocompromised Patients without Human Immunodeficiency Virus on Intravenous Pentamidine Prophylaxis: A …
Background: Trimethoprim-sulfamethoxazole (TMP-SMX) is a first-line Pneumocystis
pneumonia (PCP) prophylaxis agent, but monthly intravenous pentamidine (IVP) is used in …
pneumonia (PCP) prophylaxis agent, but monthly intravenous pentamidine (IVP) is used in …
Safety and efficacy of intravenous pentamidine in children and adolescents undergoing hematopoietic stem cell transplantation
J DeMasi, J Cox, A Koh, VM Aquino - Biology of Blood and Marrow …, 2012 - astctjournal.org
Background Pneumocystis carnii pneumonia (PCP) is a potentially life-threatening but
preventable infection that may occur after hematopoietic stem cell transplantation (HSCT) …
preventable infection that may occur after hematopoietic stem cell transplantation (HSCT) …
Safety and effectiveness of intravenous pentamidine for prophylaxis of Pneumocystis jirovecii pneumonia in pediatric hematology/oncology patients
LJ Solodokin, LM Klejmont, MR Scipione… - Journal of Pediatric …, 2016 - journals.lww.com
Background: Pneumocystis jirovecii pneumonia (PCP) is an opportunistic infection that can
lead to significant morbidity and mortality in immunocompromised pediatric …
lead to significant morbidity and mortality in immunocompromised pediatric …
Primary Pneumocystis carinii prophylaxis with aerosolized pentamidine after bone marrow transplantation
CM Machado, MCA Macedo, RSS Medeiros… - Acta …, 1998 - karger.com
Patients undergoing immunosuppressive therapy have a 21% risk of developing
Pneumocystis carinii pneumonia (PCP) if no prophylaxis is used [1]. During the first 6 …
Pneumocystis carinii pneumonia (PCP) if no prophylaxis is used [1]. During the first 6 …